Abstract Glioblastoma is a lethal brain tumour for which current multimodal treatment rarely prevents recurrence1. Therapeutic failure is driven by extensive intratumoural cellular heterogeneity2 with a microenvironment dominated by tumour-associated macrophages that sustain tumour growth and immunosuppression3.
Thomas Kislinger
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Get in touch with Thomas
Contact Thomas, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack